Will You Gain the Weight Back If You Stop a GLP-1?

GLP-1 receptor agonists like semaglutide and tirzepatide have helped millions of people lose significant weight and better manage blood sugar. But what happens when you stop taking them? Here is what the science says.

Will I gain the weight back?

For most people, yes. Research published in the journal Diabetes, Obesity and Metabolism found that participants who stopped taking semaglutide regained approximately two-thirds of their lost weight within one year of discontinuation. A separate study following participants from the STEP 1 clinical trial found that weight, waist circumference and cardiometabolic risk factors largely returned toward baseline levels within 12 months of stopping the medication.

This does not mean weight regain is inevitable or total, but it does reflect an important biological reality: GLP-1 medications work in part by suppressing appetite and slowing gastric emptying, and when the medication stops, those effects stop too. For many patients, hunger returns, sometimes intensely, and without the drug’s support, maintaining the same caloric intake becomes significantly harder.

Why does the weight come back so quickly?

Obesity is a chronic disease with strong biological drivers. GLP-1 medications address those drivers pharmacologically, much like blood pressure medication manages hypertension. Stopping the medication does not reset the underlying biology. Research suggests that the hormonal and metabolic factors that contribute to weight gain, including elevated ghrelin levels and reduced satiety signaling, tend to reassert themselves after discontinuation.

This is why many clinicians now frame GLP-1 therapy as a long-term or potentially lifelong intervention for patients with obesity, rather than a short-term course of treatment.

There is also recent data suggesting that abrupt discontinuation may result in a transient mismatch between increased biological drive for weight regain and the sudden loss of pharmacological appetite suppression.

What happens to blood sugar control if I stop?

For patients using GLP-1 medications to manage Type 2 diabetes, stopping can lead to a rise in blood glucose levels. The degree of that rise depends on the individual, their other medications, their diet and their level of physical activity. Patients should never stop a GLP-1 medication without consulting their prescribing physician, particularly if it is part of a diabetes management plan.

Are there withdrawal symptoms?

GLP-1 medications are not considered addictive and do not produce withdrawal symptoms in the traditional sense. However, patients frequently report a return of appetite, food cravings and, in some cases, a heightened preoccupation with eating after stopping. This is not a psychological failing. It reflects the brain and gut returning to their premedication baseline.

Some patients also report changes in energy levels and mood following discontinuation, though more research is needed to fully characterize these effects.

What should I do if I need to stop?

If cost, supply shortages or side effects are driving the decision to stop, talking to a prescribing physician about alternatives is an important first step. Options may include switching to a different GLP-1 medication, adjusting the dose, or developing a plan to support weight maintenance through nutrition and behavioral strategies during the gap.

Building sustainable habits around protein intake, resistance training and sleep while on the medication can help buffer against rapid regain if discontinuation becomes necessary. One should not underestimate the importance of lifestyle changes while on the medication.

The bottom line

Stopping a GLP-1 medication does not erase the progress made while taking it, but maintaining that progress without pharmacological support requires intentional effort. For many patients, GLP-1 therapy is most effective when when combined with lifestyle and viewed as one part of a broader, long-term approach to metabolic health rather than a standalone solution with a defined end point.